Search

everythinglearnresearchcommunity

for

Search:↓

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Classifying hair diseases, like alopecia, is difficult and needs more research to understand their causes.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Leflunomide is more likely to help treat alopecia areata than cause it.

The combination treatment showed a higher response rate but no significant survival benefits.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Ginsenoside Rg3 combined with minoxidil was more effective in treating hair loss in mice.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Minoxidil use during pregnancy can cause excessive hair growth and multiple birth defects in the baby.

Not getting enough vitamin D can lead to health problems, so kids over one should get 600 IU/day.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Scalp cooling can help prevent hair loss from chemotherapy, but treatment should be tailored to the individual and more research is needed.

Most pediatric cancer patients in the study developed skin problems, often due to their cancer treatment.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Exosomes show promise for future tissue regeneration.